SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-16-009283
Filing Date
2016-04-20
Accepted
2016-04-20 16:10:12
Documents
5
Effectiveness Date
2016-04-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a_042016.htm DEFA14A 11905
2 GRAPHIC card_1.jpg GRAPHIC 116662
3 GRAPHIC card_2.jpg GRAPHIC 183071
4 GRAPHIC card_3.jpg GRAPHIC 67443
5 GRAPHIC card_4.jpg GRAPHIC 38338
  Complete submission text file 0001171843-16-009283.txt   571974
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 161581478
SIC: 3841 Surgical & Medical Instruments & Apparatus